NOTE: Please read recent SEC filings of the Company. Since 2023 we have implemented significant cost reductions, including termination of all employment contracts and de-registration with the SEC. There can be no certainty or conclusion on the future of the Company.
Virosomes are enveloped virus like particles. They are lipid-based carriers (envelopes) containing the functional fusion viral proteins and natural membrane proteins of the natural virus. These lipid-based viral envelopes can be combined with additional rationally designed antigens and adjuvants for each specifics vaccine or immunotherapies.
Virosomes based vaccines are designed to maintain the immunogenicity of a live-attenuated virus but with the safety of a killed virus. The virosomes are devoid of the nucleocapsid and without the genetic material of the source virus, they are unable to replicate, cause an infection or a disease. They can include, on the same particle, additional specific antigens and adjuvants. Virosomes are presented to the immune system in the most natural manner, with the aim of containing the viral proteins and keep the fusion capacity of the virosome. Thereby it optimizes the immune response against the specific antigens or viral proteins for later infection / exposure to the original virus or pathogen.
